Back to trial details

Intake questionnaire

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Applying to University of Chicago Comprehensive Cancer Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 99 years old?
2. Have you been diagnosed with HER2-negative Breast Cancer?
3. Are you able to travel to Chicago for study visits?